Clinical Trials Logo
  1. Home
  2. Arthroplasty, Replacement
  3. NCT04372173

An Evaluation of Clotting Factor Activity Before and After Total Hip Arthroplasty — CloFaTHA  

Arthroplasty, Replacement Clinical Trial

Official title:
A Comprehensive Evaluation of Thrombotic/Fibrinolytic Activation Before and After Total Hip Arthroplasty

Clinical Trial Summary

The objective of the study was to analyze both the concentration and the activity of the clotting factors, D-dimer levels, as well as fibrinogen concentration in patients who underwent primary total hip arthroplasty due to idiopathic arthrosis.

Blood loss is often related to perioperative period and may result in decrease of concentration of coagulation factors, which in turn may lead to increased bleeding. We analyzed data of thirty patients scheduled for primary hip arthroplasty: the activity of clotting factors II, VIII, X, as well as fibrinogen concentration in the following time points: (i) before surgery, (ii) six hours after the procedure, and (iii) two, (iv) four, and (v) six days after the operation. All laboratory tests were performed using automatic analyzer. At the same time intervals, an immunoenzymatic assay was used to determine D-dimer levels.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04372173
Study type Observational
Source Military Institute of Medicine, Poland
Contact
Status Completed
Phase
Start date February 1, 2018
Completion date January 31, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT02728661 - Patient-Centered Weight Loss Program for Knee Replacement Patients Phase 1/Phase 2
Recruiting NCT04080401 - Effectiveness of a Novel Gaming System on Post-operative Rehabilitation Outcomes After Total Knee Arthroplasty N/A
Completed NCT02648958 - Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations N/A
Completed NCT00846807 - Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery N/A
Recruiting NCT01909375 - American Joint Replacement Registry
Terminated NCT01153698 - Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery
Completed NCT01184989 - Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate Phase 4
Active, not recruiting NCT00114036 - Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE) N/A
Completed NCT03407885 - The Impact of Medicare Bundled Payments N/A
Completed NCT01857349 - Efficacy of Surgical Preparation Solutions in Knee Surgery N/A
Completed NCT00847301 - Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery N/A
Recruiting NCT04697004 - SMR Stemless Reverse vs SMR Reverse Shoulder System N/A
Completed NCT03158623 - Wound Additives in Primary Total Joint Athroplasty Phase 3